Emildap Trio Forte Tablet ER is a combination medication that contains Dapagliflozin, Metformin, and Sitagliptin designed to support effective blood glucose management. Dapagliflozin works by preventing the kidneys from reabsorbing excess glucose so that it can be removed through urine. Metformin helps reduce the production of glucose in the liver and improves insulin sensitivity in the body. Sitagliptin enhances the activity of hormones that help regulate insulin secretion and control blood sugar levels after meals. The extended release formulation allows the medicine to release gradually for long lasting action. Together these medicines help provide better glycemic control and support stable blood sugar levels throughout the day. Maintaining controlled glucose levels is essential for preventing diabetes related complications and supporting overall metabolic health. This medicine is usually used along with proper diet and regular physical activity. When taken as prescribed by a healthcare professional, Emildap Trio Forte Tablet ER helps maintain effective blood sugar control.